New final guidelines were expected Thursday from the Patented Medicine Prices Review Board, an arm’s-length and quasi-judicial agency that sets the maximum price drug companies can charge for new therapies, but they were delayed until next week.
Singh demands Afghan interpreters' families be allowed into Canada as Taliban surges
Singh says the resettlement program needs to be expanded.
